https://scholars.lib.ntu.edu.tw/handle/123456789/494973
標題: | Randomized phase II trial of gefitinib with and without pemetrexed as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer with activating epidermal growth factor receptor mutations | 作者: | Cheng Y. Murakami H PAN-CHYR YANG He J Nakagawa K Kang J.H Kim J.-H Wang X Enatsu S Puri T Orlando M CHIH-HSIN YANG |
公開日期: | 2016 | 出版社: | American Society of Clinical Oncology | 卷: | 34 | 期: | 27 | 起(迄)頁: | 3258-3266 | 來源出版物: | Journal of Clinical Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84989899472&doi=10.1200%2fJCO.2016.66.9218&partnerID=40&md5=91e5c828918d25a2dd7ae6f808db254c https://scholars.lib.ntu.edu.tw/handle/123456789/494973 |
ISSN: | 0732-183X | DOI: | 10.1200/JCO.2016.66.9218 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。